Regulation of cardiovascular cell function by hydrogen sulfide (H 2S)

Cell Biochemistry and Function

Volumn 28, Issue 2, 2010, Pages 95-106

  Elsey, David J ^a   Fowkes, Robert C ^b   Baxter, Gary F ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Cardiovascular; Cystathionase; Cysteine; Hydrogen sulfide; Sulphur metabolism

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; BISULFITE; CHLERLERYTHRINE; CYSTATHIONINE BETA SYNTHASE; CYSTATHIONINE GAMMA LYASE; DEXTRO LEVO PROPARGYLGLYCINE; DICLOFENAC; FORSKOLIN; GLIBENCLAMIDE; HYDROGEN SULFIDE; ISOPRENALINE; LYASE INHIBITOR; MESNA; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PINACIDIL; POTASSIUM CHANNEL BLOCKING AGENT; PROTEIN; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; PROTEIN KINASE C INHIBITOR; SODIUM 5 HYDROXYDECANOIC ACID; SODIUM SULFIDE; UNCLASSIFIED DRUG; WORTMANNIN;

ANGIOGENESIS; ANTIHYPERTENSIVE ACTIVITY; APOPTOSIS; BIOCHEMISTRY; BIOSYNTHESIS; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CELL FUNCTION; CELL PROLIFERATION; CELL PROTECTION; CHRONOTROPISM; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME METABOLISM; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INOTROPISM; MEDIATOR; MEMBRANE CURRENT; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PULMONARY HYPERTENSION; REGULATORY MECHANISM; REPERFUSION INJURY; REVIEW; SHOCK; SIGNAL TRANSDUCTION; SMOOTH MUSCLE TONE; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION;

ANIMALS; BLOOD PRESSURE; CATTLE; HUMANS; HYDROGEN SULFIDE; INFLAMMATION MEDIATORS; KATP CHANNELS; MUSCLE, SMOOTH, VASCULAR; MYOCARDIAL REPERFUSION INJURY; NITRIC OXIDE; RATS;

EID: 77249096370     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1618     Document Type: Review

References (85)

1. Petersen LC. The effect of inhibitors on the oxygen kinetics of cytochrome c oxidase. Biochim Biophys Acta 1977; 460(2): 299-307.
2. Smith RP, Gosselin RE. Hydrogen sulfide poisoning. J Occup Med 1979; 21(2): 93-97.
3. Lambert TW, Goodwin VM, Stefani D, Strosher L. Hydrogen sulfide (H2S) and sour gas effects on the eye. A historical perspective. Sci Total Environ 2006; 367(1): 1-22.
4. Warenycia MW, Goodwin LR, Benishin CG, et al. Acute hydrogen sulfide poisoning. Demonstration of selective uptake of sulfide by the brainstem by measurement of brain sulfide levels. Biochem Pharmacol 1989; 38(6): 973-981.
5. Goodwin LR, Francom D, Dieken FP, et al. Determination of sulfide in brain tissue by gas dialysis/ion chromatography: postmortem studies and two case reports. J Anal Toxicol 1989; 13(2): 105-109.
6. Abe K, Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci 1996; 16(3): 1066-1071.
7. Hosoki R, Matsuki N, Kimura H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun 1997; 237(3): 527-531.
8. Tang C, Li X, Du J. Hydrogen sulfide as a new endogenous gaseous transmitter in the cardiovascular system. Curr Vasc Pharmacol 2006; 4(1): 17-22.
9. Moore PK, Bhatia M, Moochhala S. Hydrogen sulfide: from the smell of the past to the mediator of the future? Trends Pharmacol Sci 2003; 24(12): 609-611.
10. Chen P, Poddar R, Tipa EV, et al. Homocysteine metabolism in cardiovascular cells and tissues: implications for hyperhomocysteinemia and cardiovascular disease. Adv Enzyme Regul 1999; 39: 93-109.
11. Stipanuk MH, Beck PW. Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat. Biochem J 1982; 206(2): 267-277.
12. Selhub J. Homocysteine metabolism. Annu Rev Nutrit 1999; 19: 217-246.
13. Griffith OW. Mammalian sulfur amino acid metabolism: an overview. Methods Enzymol 1987; 143: 366-376.
14. Zhao W, Wang R. H(2)S-induced vasorelaxation and underlying cellular and molecular mechanisms. Am J Physiol Heart Circ Physiol 2002; 283(2): H474-480.
15. ZhaoW, Zhang J, Lu Y,Wang R. The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. Embo J 2001; 20(21): 6008-6016.
16. 2S generated by heart in rat and its effects on cardiac function. Biochem Biophys Res Commun 2004; 313(2): 362-368.
17. Swaroop M, Bradley K, Ohura T, et al. Rat cystathionine beta-synthase. Gene organization and alternative splicing. J Biol Chem 1992; 267(16): 11455-11461.
18. Ishigami M, Hiraki K, Umemura K, Ogasawara Y, Ishii K, Kimura H. A source of hydrogen sulfide and a mechanism of its release in the brain. Antiox Redox Signal 2009; 11: 205-214.
19. Beauchamp RO ,Jr, Bus JS, Popp JA, Boreiko CJ, Andjelkovich DA. A critical review of the literature on hydrogen sulfide toxicity. Crit Rev Toxicol 1984; 13(1): 25-97.
20. Collin M, Anuar FB, Murch O, Bhatia M, Moore PK, Thiemermann C. Inhibition of endogenous hydrogen sulfide formation reduces the organ injury caused by endotoxamia. Br J Pharmacol 2005; 146(4): 498-505.
21. 2S in rat tissues. Can J Physiol Pharmacol 2003; 81(9): 848-853.
22. Mok YY, Atan MS, Yoke Ping C, et al. Role of hydrogen sulfide in haemorrhagic shock in the rat: protective effect of inhibitors of hydrogen sulfide biosynthesis. Br J Pharmacol 2004; 143(7): 881-889.
23. Li L, Bhatia M, Zhu YZ, et al. Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. Faseb J 2005; 19(9): 1196-1198.
24. Whiteman M, Li L, Kostetski I, et al. Evidence for the formation of a novel nitrosothiol from the gaseous mediators nitric oxide and hydrogen sulfide. Biochem Biophys Res Commun 2006; 343(1): 303-310.
25. 2S) - the third gas of interest for pharmacologists. Pharmacol Rep 2007; 59(1): 4-24.
26. Oh G-S, Pae H-O, Lee B-S, et al. Hydrogen sufide inhibits nitric oxide production and nuclear factor kappa-beta via heme oxygenase-1 expression in RAW264.7 macrophages stiumulated with lipolysaccharide. Free Radic Biol Med 2006; 41: 106-119.
27. Kubo S, Doe I, Kurokawa Y, Nishikawa H, Kawabata A. Direct inhibition of endothelial nitric oxide synthase by hydrogen sulfide: contribution to dual modulation of vascular tension. Toxicology 22 2007; 232(1-2): 138-146.
28. Koenitzer JR, Isbell TS, Patel HD, et al. Hydrogen sulfide mediates vasoactivity in an O2-dependent manner. Am J Physiol Heart Circ Physiol 2007; 292(4): H1953-1960.
29. Ali MY, Ping CY, Mok YY, et al. Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulfide? Br J Pharmacol 2006; 149(6): 625-634.
30. 2S is involved in the development of spontaneous hypertension. Beijing Da Xue Xue Bao 2003; 35(1): 102.
31. Chunyu Z, Junbao D, Dingfang B, Hui Y, Xiuying T, Chaoshu T. The regulatory effect of hydrogen sulfide on hypoxic pulmonary hypertension in rats. Biochem Biophys Res Commun 2003; 302(4): 810-816.
32. Zhong G, Chen F, Cheng Y, Tang C, Du J. The role of hydrogen sulfide generation in the pathogenesis of hypertension in rats induced by inhibition of nitric oxide synthase. J Hypertens 2003; 21(10): 1879-1885.
33. 2S) content during septic shock and endotoxin shock in rats. J Infect 2003; 47(2): 155-160.
34. Cai WJ, Wang MJ, Moore PK, Jin HM, Yao T, Zhu YC. The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation. Cardiovasc Res 2007; 76(1): 29-40.
35. Baskar R, Sparatore A, Del Soldato P, Moore PK. Effect of S-diclofenac, a novel hydrogen sulfide releasing derivative inhibit rat vascular smooth muscle cell proliferation. Eur J Pharmacol 2008; 594(1-3): 1-8.
36. 2S on human aorta smooth muscle cells. FASEB J 2006; 20: 553-555.
37. Yang G, Sun X,Wang R. Hydrogen sulfide-induced apoptosis of human aorta smooth muscle cells via the activation of mitogen-activated protein kinases and caspase-3. FASEB J 2004; 18: 1782-1784.
38. Meng QH, Yang G, Yang W, Jiang B, Wu L, Wang R. Protective effect of hydrogen sulfide on balloon injury-induced neointima hyperplasia in rat carotid arteries. Am J Pathol 2007; 170: 1406-1414.
39. + channels protect the myocardium against ischemia/reperfusion damage. Circ Res 1991; 69(3): 571-581.
40. Yong QC, Pan TT, Hu LF, Bian JS. Negative regulation of beta-adrenergic function by hydrogen sulfide in the rat hearts. J Mol Cell Cardiol 2008; 44(4): 701-710.
41. Ji Y, Pang QF, Xu G, Wang L, Wang JK, Zeng YM. Exogenous hydrogen sulfide postconditioning protects isolated rat hearts against ischemia-reperfusion injury. Eur J Pharmacol 2008; 587(1-3): 1-7.
42. Elrod JW, Calvert JW, Morrison J, et al. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci USA 2007; 104(39): 15560-15565.
43. Xu M, Wu YM, Li Q, Wang X, He RR. Electrophysiological effects of hydrogen sulfide on pacemaker cells in sinoatrial nodes of rabbits. Sheng Li Xue Bao 25 2008; 60(2): 175-180.
44. Ferdinandy P, Schulz R, Baxter GF. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev. 2007; 59(4): 418-458.
45. Geng B, Chang L, Pan C, et al. Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol. Biochem Biophys Res Commun 4 2004; 318(3): 756-763.
46. 2S) protects against regional myocardial ischemia-reperfusion injury-Evidence for a role of KATP channels. Basic Res Cardiol 2006; 101(1): 53-60.
47. Bian JS, Yong QC, Pan TT, et al. Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. J Pharmacol Exp Ther 2006; 316(2): 670-678.
48. Pan TT, Feng ZN, Lee SW, Moore PK, Bian JS. Endogenous hydrogen sulfide contributes to the cardioprotection by metabolic inhibition preconditioning in the rat ventricular myocytes. J Mol Cell Cardiol 2006; 40(1): 119-130.
49. Hu Y, Chen X, Pan TT, et al. Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways. Pflugers Arch 2008; 455(4): 607-616.
50. Sivarajah A, McDonald MC, Thiemermann C. The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat. Shock 2006; 26(2): 154-161.
51. Rossoni G, Sparatore A, Tazzari V, Manfredi B, Del Soldato P, Berti F. The hydrogen sulfide-releasing derivative of diclofenac protects against ischemia-reperfusion injury in the isolated rabbit heart. Br J Pharmacol 2008; 153(1): 100-109.
52. Osipov RM, Robich MP, Feng J, et al. Effect of hydrogen sulfide in a porcine model of myocardial ischemia-reperfusion: comparison of different administration regimens and characterization of the cellular mechanisms of protection. J Cardiovasc Pharmacol 2009; in press (ahead of print).
53. Griffiths EJ, Halestrap AP. Mitochondrial non-specific pores remain closed during cardiac ischemia, but open upon reperfusion. Biochem J. 1995; 307(Pt 1): 93-98.
54. Hausenloy DJ, Ong SB, Yellon DM. The mitochondrial permeability transition pore as a target for preconditioning and postconditioning. Basic Res Cardiol 2009; 104: 189-202.
55. Hausenloy DJ, Maddock HL, Baxter GF, Yellon DM. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc Res 15 2002; 55(3): 534-543.
56. Hausenloy DJ, Yellon DM. Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. Heart Fail Rev 2007; 12(3-4): 217-234.
57. 2S preconditioning-induced PKC activation regulates intracellular calcium handling in rat cardiomyocytes. Am J Physiol 2008; 294(1): C169-177.
58. Yong QC, Lee SW, Foo CS, Neo KL, Chen X, Bian JS. Endogenous hydrogen sulfide mediates the cardioprotection induced by ischemic postconditioning. Am J Physiol Heart Circ Physiol 2008; 295(3): H1330-H1340.
59. Skyschally A, van Caster P, Boengler K, et al. Ischemic postconditioning in pigs: no causal role for RISK activation. Circ Res 2009; 104(1): 15-18.
60. Musiolik J, van Caster P, Skyschally A, et al. Reduction of infarct size by gentle reperfusion without activation of reperfusion injury salvage kinases in pigs. Cardiovasc Res 2009; in press (ahead of print).
61. Zhang H, Zhi L, Moore PK, Bhatia M. Role of hydrogen sulfide in cecal ligation and puncture-induced sepsis in the mouse. Am J Physiol Lung Cell Mol Physiol 2006; 290: L1193-1201.
62. Zanardo RC, Brancaleone V, Distrutti E, Fiorucci S, Cirino G, Wallace JL. Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. Faseb J 2006; 20(12): 2118-2120.
63. Nagai Y, Tsugane M, Oka J, Kimura H. Hydrogen sulfide induces calcium waves in astrocytes. Faseb J 2004; 18(3): 557-559.
64. Mariggio MA, Pettini F, Fumarulo R. Sulfide influence on polymorphonuclear functions: a possible role for Ca2+ involvement. Immunopharm Immunotox 1997; 19(3): 393-404.
65. Mitsuhashi H, Nojima Y, Tanaka T, et al. Sulfite is released by human neutrophils in response to stimulation with lipopolysaccharide. J Leukocyte Biol 1998; 64(5): 595-599.
66. Mitsuhashi H, Ikeuchi H, Yamashita S, et al. Increased levels of serum sulfite in patients with acute pneumonia. Shock 2004; 21(2): 99-102.
67. Labbe P, Pelletier M, Omara FO, Girard D. Functional responses of human neutrophils to sodium sulfite (Na2SO3) in vitro. Hum Exp Toxicol 1998; 17(11): 600-605.
68. Shigehara T, Mitsuhashi H, Ota F, et al. Sulfite induces adherence of polymorphonuclear neutrophils to immobilized fibrinogen through activation of Mac-1 beta2-integrin (CD11b/CD18). Life Sci 2002; 70(19): 2225-2232.
69. Reist M, Jenner P, Halliwell B. Sulfite enhances peroxynitrite-dependent alpha1-antiproteinase inactivation. A mechanism of lung injury by sulphur dioxide? FEBS Lett. 1998; 423(2): 231-234.
70. Qingyou Z, Junbao D, Weijin Z, Hui Y, Chaoshu T, Chunyu Z. Impact of hydrogen sulfide on carbon monoxide/heme oxygenase pathway in the pathogenesis of hypoxic pulmonary hypertension. Biochem Biophys Res Commun 2004; 317(1): 30-37.
71. Ryter SW, Alam J, Choi AM. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 2006; 86(2): 583-650.
72. Christen WG, Ajani UA, Glynn RJ, Hennekens CH. Blood levels of homocysteine and increased risks of cardiovascular disease: causal or casual? Arch Intern Med 2000; 160(4): 422-434.
73. Jiang HL, Wu HC, Li ZL, Geng B, Tang CS. Changes of the new gaseous transmitter H2S in pateints with coronary heart disease. Di Yi Jun Yi Da Xue Xue Bao 2005; 25(8): 951-954.
74. Bliksoen M, Kaljusto ML, Vaage J, Stenslokken KO. Effects of hydrogen sulfide on ischemia-reperfusion injury and ischemic preconditioning in the isolated, perfused rat heart. Eur J Cardiothorac Surg 2008; 34(2): 344-349.
75. Li L, Moore PK. Putative biological roles of hydrogen sulfide in health and disease: a breath of not so fresh air? Trends Pharmacol Sci 2008; 29(2): 84-90.
76. Li L, Whiteman M, Guan YY, et al. Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide. Circulation 2008; 117(18): 2351-2360.
77. Li L, Rossoni G, Sparatore A, Lee LC, Del Soldato P, Moore PK. Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative. Free Radic Biol Med 2007; 42: 706-719.
78. Mason J, Cardin CJ, Dennehy A. The role of sulfide and sulfide oxidation in the copper molybdenum antagonism in rats and guinea pigs. Res Vet Sci 1978; 24(1): 104-108.
79. Richardson CJ, Magee EA, Cummings JH. A new method for the determination of sulfide in gastrointestinal contents and whole blood by microdistillation and ion chromatography. Clin Chim Acta 2000; 293(1-2): 115-125.
80. Zhang Z, Huang H, Liu P, Tang C, Wang J. Hydrogen sulfide contributes to cardioprotection during ischemia-reperfusion injury by opening K ATP channels. Can J Physiol Pharmacol 2007; 85(12): 1248-1253.
81. Zhu YZ,Wang ZJ, Ho P, et al. Hydrogen sulfide and its possible roles in myocardial ischemia in experimental rats. J Appl Physiol 2007; 102(1): 261-268.
82. Sivarajah A, Collino M, Yasin M, et al. Antiapoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional myocardial I/R. Shock 2009; 31: 267-274.
83. 2S protects myocardium against ischemia/ reperfusion injury and its effect on c-Fos protein expression in rats. Sheng Li Xue Bao 2008; 60(2): 221-227.
84. Sodha NR, Clements RT, Feng J, et al. The effects of therapeutic sulfide on myocardial apoptosis in response to ischemia-reperfusion injury. Eur J Cardiothorac Surg 2008; 33(5): 906-913.
85. Wang R. The gasotransmitter role of hydrogen sulfide. Antioxid Redox Signal 2003; 5(4): 493-501.